Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome

NCT00356733 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure, Congestive
Renal Insufficiency, Chronic

Interventions

DRUG: Erythropoietin administration

Sponsor

UMC Utrecht

Collaborators

[object Object]